Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-336509
Filing Date
2017-11-08
Accepted
2017-11-08 08:02:50
Documents
44
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d445348d10q.htm 10-Q 229742
2 EX-10.1 d445348dex101.htm EX-10.1 280118
3 EX-31.1 d445348dex311.htm EX-31.1 9166
4 EX-31.2 d445348dex312.htm EX-31.2 9352
5 EX-32.1 d445348dex321.htm EX-32.1 4776
  Complete submission text file 0001193125-17-336509.txt   2324049

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT meip-20170930.xml EX-101.INS 268961
7 XBRL TAXONOMY EXTENSION SCHEMA meip-20170930.xsd EX-101.SCH 27779
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE meip-20170930_cal.xml EX-101.CAL 31936
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE meip-20170930_def.xml EX-101.DEF 179507
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20170930_lab.xml EX-101.LAB 255397
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20170930_pre.xml EX-101.PRE 208008
Mailing Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-50484 | Film No.: 171185139
SIC: 2834 Pharmaceutical Preparations